Kenvue (US:KVUE)2025-08-07 12:30Financial Performance - Q2 2025 - Net sales declined by 40% year-over-year, reaching $38 billion in Q2 2025, compared to $40 billion in Q2 2024[27] - Organic sales decreased by 42% compared to the previous year[26] - Adjusted gross profit margin was 609%, a decrease of 70 basis points year-over-year[26, 46] - Adjusted operating income margin was 227%, a decrease of 10 basis points year-over-year[26, 46] - Adjusted diluted earnings per share were $029[26] Segment Performance - Q2 2025 - Self Care net sales were $16 billion, with a 49% reported decrease and a 59% organic sales decrease[28] - Skin Health & Beauty net sales were $11 billion, with a 40% reported decrease and a 37% organic sales decrease[33] - Essential Health net sales were $12 billion, with a 29% reported decrease and a 24% organic sales decrease[40] 2025 Outlook - The company updated its 2025 outlook, projecting a decrease in reported net sales growth in the low single digits (LSD)[23, 49] - Organic sales growth is also expected to decrease in the low single digits[49] - Adjusted diluted earnings per share are projected to be in the range of $100 to $105, assuming a full-year diluted weighted average share count of 193 billion[49] Strategic Initiatives - The Kenvue Board is undertaking a comprehensive review of strategic alternatives to unlock shareholder value[14, 57] - New leadership is focused on bolstering leadership & capabilities, reviewing operating strategy, improving execution, and optimizing structure & operating model[57]